MarketCap
Becton, Dickinson and Company BDX
Facebook
X
Telegram
Country |
 USA |
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NYSESPB |
Shares |
288 M |
Market Cap[1] |
$ 61.4 B |
EBITDA (LTM) |
$ 6.1 B |
P/E (LTM) |
28.820593 |
P/S (LTM) |
2.466813 |
EPS (LTM) |
6.41 |
Becton, Dickinson and Company is an international company specializing in the development and production of medical devices and technologies for the diagnosis and treatment of various diseases. The company was founded in 1897 in the United States and today is one of the largest manufacturers of medical devices in the world.
BDX offers a wide range of medical devices, including syringes, needles, blood collection systems, microbiological and diagnostic systems, and more. The company also provides training for healthcare professionals, consultations, and support for patients.
The company has offices worldwide and serves patients in more than 190 countries. The headquarters are located in New Jersey, USA.
Becton, Dickinson and Company's goal is to help people lead healthy lifestyles by providing them with innovative medical devices and technologies. The company actively works on developing new products and improving the quality of its services to meet the needs of its customers.
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
$ 38.61 | 3.51 % | $ 1.84 B | Nasdaq Global Select Market | USA |
 |
Alcon
ALC
|
$ 74.11 | -1.37 % | $ 36.6 B | NYSE |  Schweiz |
 |
Baxter International
BAX
|
$ 26.43 | 0.06 % | $ 13.6 B | NYSE,SPB | USA |
 |
The Cooper Companies
COO
|
$ 63.6 | -0.52 % | $ 12.7 B | NYSE,SPB | USA |
 |
electroCore
ECOR
|
$ 7.68 | 6.96 % | $ 65.1 M | Nasdaq Global Select Market | USA |
 |
ResMed
RMD
|
$ 234.15 | -0.67 % | $ 34.1 B | NYSE,SPB | USA |
 |
Retractable Technologies
RVP
|
$ 0.55 | -1.5 % | $ 16.5 M | NYSE American | USA |
 |
STAAR Surgical Company
STAA
|
$ 24.25 | -1.22 % | $ 1.2 B | Nasdaq Global Market,SPB | USA |
 |
STERIS plc
STE
|
$ 257.0 | 0.02 % | $ 25.2 B | NYSE,SPB | USA |
 |
Teleflex Incorporated
TFX
|
$ 155.37 | 0.27 % | $ 6.93 B | NYSE,SPB | USA |
 |
Utah Medical Products
UTMD
|
$ 72.86 | -0.01 % | $ 236 M | Nasdaq Global Select Market | USA |
 |
West Pharmaceutical Services
WST
|
$ 412.49 | -0.08 % | $ 29.8 B | NYSE,SPB | USA |
 |
InfuSystem Holdings
INFU
|
$ 15.24 | 3.81 % | $ 315 M | NYSE American | USA |
 |
DENTSPLY SIRONA
XRAY
|
$ 9.77 | 2.36 % | $ 1.95 B | Nasdaq Global Select Market,SPB | USA |
 |
iRhythm Technologies
IRTC
|
$ 86.01 | -3.07 % | $ 2.75 B | Nasdaq Global Select Market,SPB | USA |
 |
Intuitive Surgical
ISRG
|
$ 449.99 | -2.3 % | $ 161 B | Nasdaq Global Select Market,SPB | USA |
 |
Repro Med Systems
KRMD
|
$ 3.17 | -1.86 % | $ 146 M | Nasdaq Capital Market | USA |
 |
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | USA |
 |
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | USA |
 |
AtriCure
ATRC
|
$ 56.21 | -2.74 % | $ 2.68 B | Nasdaq Global Market,SPB | USA |
 |
AngioDynamics
ANGO
|
$ 12.07 | -0.45 % | $ 501 M | Nasdaq Global Select Market | USA |
 |
Glaukos Corporation
GKOS
|
$ 236.28 | -1.03 % | $ 13.5 B | NYSE,SPB | USA |
 |
Harvard Bioscience
HBIO
|
$ 9.39 | 3.3 % | $ 417 M | Nasdaq Global Market | USA |
 |
OraSure Technologies
OSUR
|
$ 3.41 | -3.54 % | $ 251 M | Nasdaq Global Select Market,SPB | USA |
 |
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | USA |
 |
Microbot Medical
MBOT
|
$ 1.06 | -4.09 % | $ 48.5 M | Nasdaq Global Select Market |  Israel |
 |
Haemonetics Corporation
HAE
|
$ 122.34 | 3.49 % | $ 5.77 B | NYSE,SPB | USA |
 |
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | USA |
 |
ICU Medical
ICUI
|
$ 182.28 | 1.86 % | $ 4.49 B | Nasdaq Global Select Market,SPB | USA |
 |
Milestone Scientific
MLSS
|
$ 0.3 | -0.36 % | $ 24.6 M | NYSE American | USA |
 |
Merit Medical Systems
MMSI
|
$ 87.87 | -0.62 % | $ 5.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Nephros
NEPH
|
$ 3.13 | 4.33 % | $ 33.2 M | Nasdaq Global Select Market | USA |
 |
Pro-Dex
PDEX
|
$ 70.6 | 0.43 % | $ 228 B | Nasdaq Global Select Market | USA |
 |
Envista Holdings Corporation
NVST
|
$ 25.87 | -0.19 % | $ 4.35 B | NYSE | USA |
 |
LeMaitre Vascular
LMAT
|
$ 78.94 | -2.74 % | $ 1.79 B | Nasdaq Global Market,SPB | USA |
 |
Pulse Biosciences
PLSE
|
$ 55.1 | -5.28 % | $ 3.71 B | Nasdaq Global Select Market | USA |
 |
Repligen Corporation
RGEN
|
$ 174.04 | -2.74 % | $ 9.79 B | Nasdaq Global Select Market,SPB | USA |
 |
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | USA |
 |
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | USA |
 |
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | USA |
 |
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | USA |
 |
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | USA |
 |
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | USA |
 |
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Stereotaxis
STXS
|
$ 1.05 | -7.89 % | $ 95.5 M | NYSE American | USA |
 |
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.